Table 1 Clinical characteristics of 132 patients
Characteristics | Values |
|---|---|
Gender | |
Male Female | 88(66.7%) 44(33.3%) |
Age (years, median, IQR) | 65 (56–70) |
KPS | |
≥ 80 < 80 | 116 (87.9%) 16 (12.1) |
Primary tumor | |
Colorectal carcinoma Lung carcinoma Head-neck carcinoma Gastric carcinoma Skin and soft tissue carcinoma Urinary system carcinoma Hepatobiliary carcinoma Breast carcinoma Reproductive system carcinoma Thymic carcinoma Esophageal carcinoma Unknown | 36 (27.3%) 25 (18.9%) 15 (11.4%) 11 (8.3%) 10 (7.6%) 7 (5.3%) 7 (5.3%) 6 (4.5%) 5 (3.8%) 5 (3.8%) 4 (3.0%) 1 (0.8%) |
Pathological grade | |
High-grade Low-grade Unknown | 61 (46.2%) 44 (33.3%) 27 (20.5%) |
Number of metastases | |
1 ≥ 2 | 47 (35.6%) 85 (64.4%) |
Seed implantation site | |
Thoracic wall Abdominal wall Head and neck Arms and legs Other a | 48(36.3%) 47(35.6%) 17(12.9%) 5(3.8%) 15(11.4%) |
Maximum diameter (cm, median, IQR) | 4.2(2.6-6.0) |
Previous radiotherapy | |
Yes No | 10(7.6%) 122(92.4%) |
Previous chemotherapy | |
Yes No | 97(73.5%) 35(26.5%) |
Postoperative systemic therapy b | |
Yes No | 97(73.5%) 35(26.5%) |
cancer pain (NRS score) | |
0 1–3 4–6 7–10 | 54(40.9%) 34(25.8%) 41(31.1%) 3(2.3%) |